Institut Gustave Roussy, University of Paris Saclay, Villejuif, France.
Institute of Cancer Research, London, United Kingdom.
Carolina Urologic Research Center and GenesisCare, SC, Myrtle Beach, United States.
Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, CA, San Francisco, United States.
Massachusetts General Hospital Cancer Center, MA, Boston, United States.
South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia.
Division of Urology, Clinique Universitaire St. Luc, Brussels, Belgium.
Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland; Faculty of Biosciences, Università della Svizzera Italiana, Lugano, Switzerland.
Huntsman Cancer Institute, University of Utah, UT, Salt Lake City, United States.
Masonic Cancer Center, University of Minnesota, MN, Minneapolis, United States.
Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, TX, Houston, United States.
Center for Prostate and Urologic Cancer, Duke Cancer Institute, Duke University, NC, Durham, United States.
Hospital Sirio-Libanês, São Paulo, Brazil.
UCL Cancer Institute, University College London, London, United Kingdom.
Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Department of Urology, Akershus University Hospital, Lørenskog, Norway.
Salah Azaiz Institute, Medical School of Tunis, Tunis, Tunisia.
Department of Medical Oncology, Dana-Farber Cancer Institute, MA, Boston, United States; Harvard Medical School, MA, Boston, United States.
Department of Urology, Skåne University Hospital, Malmö, Sweden.
Department of Radiation Oncology, Oncostat U1018 INSERM, Université Paris-Saclay, Gustave-Roussy, Villejuif, France.
Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Unit of Urology/Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
Division of Urology, Department of Surgery, American University of Beirut Medical Center, Beirut, Lebanon.
Department of Oncology, San Luigi Hospital, University of Turin, Orbassano, Italy.
Medical Oncology Department, Santa Chiara Hospital, APSS, Trento, Italy.
Department of Medical Oncology, Hospital Universitario, 12 de Octubre, Madrid, Spain.
Department of Medical Oncology, Hospital Universitario, 12 de Octubre, Madrid, Spain.
Department of Medicine, Division of Hematology and Oncology, University of Washington, WA, Seattle, United States; Division of Clinical Research, Fred Hutchinson Cancer Center, WA, Seattle, United States.
BC Cancer and University of British Columbia, Vancouver, Canada.
Research Department of Primary Care and Population Health, University College London, London, United Kingdom.
The Christie and Salford Royal Hospitals, Manchester, United Kingdom.
Institute of Cancer Research, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom.
Department of Urology, Charité Universitätsmedizin Berlin, Berlin, Germany; Department of Urology, Medical University of Vienna, Vienna, Austria.
Medical Oncology Department, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.
Houston Methodist Cancer Center, TX, Houston, United States.
Urology Division, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria.
Kasr Al Ainy Hospital, Cairo University, Giza, Egypt.
Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, Australia; Faculty of Medicine, UNSW Sydney, Sydney, Australia.
Department of Nuclear Medicine, IRCCS AOU Bologna, Bologna, Italy.
Lagos State University Teaching Hospital, Ikeja, Nigeria.
University of California-San Francisco, CA, San Francisco, United States.
Auckland City Hospital and University of Auckland, Auckland, New Zealand.
Ghent University Hospital, Ghent, Belgium.
Department of Surgery (Urology Service), Ente Ospedaliero Cantonale, Università della Svizzera Italiana Lugano, Switzerland.
Departments of Medicine and Surgery, Duke Cancer Institute, Duke University, NC, Durham, United States.
Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.
Department of Medical Oncology, Institut Paoli Calmettes, Aix-Marseille Université, Marseille, France.
Department of Biostatistics and Bioinformatics, Duke University, NC, Durham, United States.
Department of Oncology and Radiotherapy, Innlandet Hospital Trust, Gjøvik, Norway.
Department of Nuclear Medicine, University of Duisburg-Essen, Essen, Germany; German Cancer Consortium, University Hospital Essen, Essen, Germany.
Prostate Cancer Theranostics and Imaging Centre of Excellence, Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
Department of Radiology and Biomedical Imaging, University of California-San Francisco, CA, San Francisco, United States.
Chris O'Brien Lifehouse, University of Sydney, Sydney, Australia.
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, IL, Chicago, United States.
Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy; Department of Radiation Oncology, European Institute of Oncology IRCCS, Milan, Italy.
School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.
Department of Medical Oncology, Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, Australia.
Division of Medical Oncology, National Cancer Centre, Singapore.
Genitourinary Unit, Division of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel.
Naef K. Basile Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon; Division of Urology, Carle-Illinois College of Medicine, IL, Urbana, United States.
Department of Urology, Medical University of Vienna, Vienna, Austria.
Department of Urology and Population Health, New York University Langone Health, NY, New York, United States; Department of Surgery/Urology, Manhattan Veterans Affairs, NY, New York, United States.
Department of Radiation Oncology, University of Miami Sylvester Cancer Center, FL, Miami, United States.
Beneficiência Portuguesa de São Paulo, São Paulo, Brazil; Departamento de Oncologia, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Faculty of Education Health and Wellbeing, University of Wolverhampton, Walsall, United Kingdom.
Department of Urology, Helsinki University Hospital, Helsinki, Finland.
Department of Medical Oncology, St. Vincent's University Hospital and Cancer Trials, Dublin, Ireland.
University of California-San Diego, CA, Palo Alto, United States.
Department of Medical Oncology, Radboudumc, Nijmegen, Netherlands.
Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany.
Department of Medical Oncology, Dana-Farber Cancer Institute, MA, Boston, United States; Brigham and Women's Hospital, Harvard Medical School, MA, Boston, United States.
Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, New York, United States.
Institut National d'Oncologie, Mohamed V University, Rabat, Morocco.
Clemenceau Medical Center, Dubai, United Arab Emirates; Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
Department of Urology, Sefako Makgatho Health Science University, Dr. George Mukhari Academic Hospital, Medunsa, South Africa.
Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, MA, Boston, United States.
Division of Hematology and Medical Oncology, Tisch Cancer Institute at Mount Sinai, NY, New York, United States.
Department of Radiation Oncology, Iridium Network, Antwerp, Belgium; Department of Human Structure and Repair, Ghent University, Ghent, Belgium.
Patrick G. Johnston Centre for Cancer Research, Queen's University, Belfast, United Kingdom.
Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, United Kingdom.
Institute of Cancer Research, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom.
Hong Kong Sanatorium and Hospital, Chinese University of Hong Kong, Hong Kong, Hong Kong.
Department of Laboratory Medicine and Pathology, University of Washington, WA, Seattle, United States.
Cancer Research Chair and Department of Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, New York, United States.
University of California-Los Angeles, CA, Los Angeles, United States.
Department of Imagery, GRC 5 Predictive Onco-Uro, Pitie-Salpetriere Hospital, AP-HP, Sorbonne University, Paris, France.
Masonic Cancer Center, University of Minnesota, MN, Minneapolis, United States.
Centre Hospitalier de Université de Montréal, Montreal, Canada.
Instituto Alexander Fleming, Buenos Aires, Argentina.
Prostate Cancer Theranostics and Imaging Centre of Excellence, Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
Department of Medical Oncology, Mayo Clinic Comprehensive Cancer Center, MN, Rochester, United States.
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, IL, Chicago, United States.
Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, New York, United States.
Desai Sethi Urology Institute and Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, FL, Miami, United States.
Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Prostate Cancer Foundation, CA, Santa Monica, United States.
Department of Radiation Oncology, University Hospitals Seidman Cancer Center, OH, Cleveland, United States.
Division of Medical Oncology, Stanford University Medical Center, CA, Stanford, United States.
Englander Institute for Precision Medicine, Weill Cornell Medicine, Division of Hematology and Oncology, Meyer Cancer Center, New York Presbyterian Hospital, NY, New York, United States.
Department of Urology, Toho University Sakura Medical Center, Sakura, Japan.
Department of Medical Oncology, Dana-Farber Cancer Institute, MA, Boston, United States.
Martini-Klinik Prostate Cancer Center and Department of Urology, University Hospital Hamburg Eppendorf, Hamburg, Germany.
Department of Urology, M.A. Aydınlar Acıbadem University, Altunizade Hospital, Istanbul, Turkey.
Yokohama City University Medical Center, Yokohama, Japan.
Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey.
MRC Clinical Trials Unit, University College London, London, United Kingdom.
Department of Radiation Oncology, Abramson Cancer Center, University of Pennsylvania, PA, Philadelphia, United States.
Institut Paoli-Calmettes Cancer Center, Marseille, France.
H. Lee Moffitt Cancer Center and Research Institute, FL, Tampa, United States.
Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Department of Medicine, Division of Hematology and Oncology, University of Washington, WA, Seattle, United States; Division of Clinical Research, Fred Hutchinson Cancer Center, WA, Seattle, United States.
University Hospital La Princesa, Health Research Institute, Madrid, Spain.
Onkozentrum Zurich, University of Zurich and Tumorzentrum Hirslanden Zurich, Zurich, Switzerland.
Elsevier, 2025. Vol. 87, nr 2, s. 157-216
Adjuvant therapy, Biochemical recurrence, Bone protection, Genetics and genomics, Hormonal treatment, Next-generation imaging, Positron emission tomography, Prostate cancer, Prostate-specific membrane antigen, Salvage therapy